Retraction
Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets
Paper Information
Record ID:
58419
Journal:
Publication Date:
September 29, 2022
Retraction Date:
December 29, 2023
(1.9 year years ago)
Subjects:
Institutions:
- Department of Radiology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi 545006, China
- Department of Radiology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China
- Faculty of Chemical Engineering & Technology, Micro System Technology, Centre of Excellence (CoE), and Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), Perlis, Malaysia
- Institute of Life Sciences, Jiangsu University, Zhengjiang, Jiangsu 212013, China
- Department of Radiology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, China
- Department of Cardiology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi 545006, China
Countries:
Article Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (10)
10
Total Citations2
Post-Retraction(20.0%)
6
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
131
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells
Manqing Tang, Zhijie Zhang, Ping Wang et al. (9 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: May 2024
9 citations
9 citations
131 days after retraction
Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy
Lijuan Liang, Yiping Deng, Zuojin Ao et al. (7 authors)
Journal of drug targeting
Open Access
Published: Apr 2024
1 citation
1 citation
117 days after retraction
Retracted: Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity
Open Access
Published: Dec 2023
Same day as retraction
Nano-modulators with the function of disrupting mitochondrial Ca2+ homeostasis and photothermal conversion for synergistic breast cancer therapy
Chenglong Wang, Tao Li, Zhen Wang et al. (11 authors)
Journal of Nanobiotechnology
Open Access
Published: Dec 2023
19 citations
19 citations
25 days before retraction
Nanomedicine for Diagnosis and Treatment of Atherosclerosis
Jingyun Cheng, Hui Huang, Yu Chen et al. (4 authors)
Advanced Science
Open Access
Published: Oct 2023
44 citations
44 citations
62 days before retraction
M2 Macrophage Membrane‐Camouflaged Fe<sub>3</sub>O<sub>4</sub>‐Cy7 Nanoparticles with Reduced Immunogenicity for Targeted NIR/MR Imaging of Atherosclerosis
Lin Zou, Yao Zhang, Nihad Cheraga et al. (10 authors)
Small
Open Access
Published: Oct 2023
11 citations
11 citations
82 days before retraction
Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy
Yiping Deng, Zuojin Ao, Jun Tang et al. (6 authors)
Authorea (Authorea)
Open Access
Published: Aug 2023
128 days before retraction
Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review
Tong-Mei Yang, Miao Miao, Wenqian Yu et al. (7 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Mar 2023
11 citations
11 citations
302 days before retraction
Key Parameters for the Rational Design, Synthesis, and Functionalization of Biocompatible Mesoporous Silica Nanoparticles
Marta Florensa, Marina Llenas, Esperanza Medina-Gutiérrez et al. (5 authors)
Pharmaceutics
Open Access
Published: Dec 2022
45 citations
45 citations
392 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025